APA (7th ed.) Citation

Q, D., R, N., F, C., S, A., Y, L., RU, R., . . . IA, A. (2022). Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1. Cell reports, 39(11), 110971. https://doi.org/10.1016/j.celrep.2022.110971

Chicago Style (17th ed.) Citation

Q, Deng, et al. "Oncofusion-driven De Novo Enhancer Assembly Promotes Malignancy in Ewing Sarcoma via Aberrant Expression of the Stereociliary Protein LOXHD1." Cell Reports 39, no. 11 (2022): 110971. https://doi.org/10.1016/j.celrep.2022.110971.

MLA (9th ed.) Citation

Q, Deng, et al. "Oncofusion-driven De Novo Enhancer Assembly Promotes Malignancy in Ewing Sarcoma via Aberrant Expression of the Stereociliary Protein LOXHD1." Cell Reports, vol. 39, no. 11, 2022, p. 110971, https://doi.org/10.1016/j.celrep.2022.110971.